Concert Pharmaceuticals, Inc.

Concert Pharmaceuticals, Inc.

Concert Pharmaceuticals, Inc.

Concert Pharmaceuticals is a biotechnology company utilizing deuterium todevelop novel medical candidates.
Type
B2b
Founded
2006
Raised
$125.5M
Follow us
Alexa global traffic share
12 Jun 2017
$30,000,000
Post-IPO debt

Concert Pharmaceuticals Announces $30 Million Venture Debt Financing from Hercules Capital

businesswire
+1